Orion quarterly operating profit jumps

HELSINKI Tue Oct 23, 2012 5:19am EDT

HELSINKI (Reuters) - Finnish drug maker Orion (ORNBV.HE) reported a 17 percent rise in quarterly operating profit, managing to make up for a fall in sales of its Stalevo drug for Parkinson's disease with other products.

Orion said its third-quarter operating profit rose to 76.3 million euros from 65.3 million euros a year earlier.

Generic competitors dented sales of its Stalevo drug in the United States, but this was offset by compensation from Novartis (NOVN.VX) and sales of other drugs, the company said.

(Reporting by Helsinki newsroom)

A couple walks along the rough surf during sunset at Oahu's North Shore, December 26, 2013. REUTERS/Kevin Lamarque

Find your dream retirement town

Florida? Hawaii? Reuters has teamed up with Zillow to give you the power to customize a list of your best places to retire.  Video | Full Article